The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2018Assessing the Effects of the Glucosylceramide Lipid on Protein Clumping
Study Rationale:
Changes (mutations) in the GBA1 gene cause Gaucher disease, a rare condition that causes fatty substances to build up and organs to swell, and increase the risk of Parkinson's disease... -
Access to Data and Biospecimens, 2018A New Test for Rapid and Ultra-Sensitive Detection of Hallmarks of Parkinson's Disease in Cerebrospinal Fluid
Study Rationale:
The diagnosis and treatment of Parkinson's disease (PD) would be aided by the availability of direct and highly sensitive tests for the abnormal clumps of protein alpha-synuclein... -
Access to Data and Biospecimens, 2018Discovery and Verification of Parkinson's Disease Biomarkers
Study Rationale:
The identification, development and use of Parkinson's disease (PD) biomarkers -- objective measures of disease -- remains a priority for researchers searching for a cure. Using a... -
Alpha-Synuclein Biology and Therapies, 2018Antisense Oligonucleotides as Drug Candidates for Alpha-Synuclein-Linked Diseases
Study Rationale:
The goal of this project is to find drugs that target alpha-synuclein, a key protein in Parkinson's disease (PD). We will design and test second-generation antisense oligonucleotides... -
Research Grant, 2018Parkin as a Protection Against Mitochondrial Stress
Promising Outcomes of Original Grant:
Parkin is one of the key proteins linked to Parkinson's disease (PD). Previously, we examined if enhanced function of parkin changes the composition and renewal of... -
Target Advancement Program, 2018Studying GLP1 Receptor as a Therapeutic Target in Parkinson's Disease
Study Rationale:
Drugs called GLP1 agonists for their ability to activate protein GLP1 receptor were originally developed to treat type 2 diabetes mellitus. However, they can travel to the brain and...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.